Combination therapy with simvastatin and ezetimibe reduces plasma levels of remnant cholesterol, apolipoprotein B/lipoprotein, triglycerides, and cholesteryl esters in patients with gallstones, potentially due to the anti-inflammatory effects of statins [44]. This evidence concerns the gene APOB and gallstones.